Literature DB >> 14599272

The hyperpriming phenomenon in normal aging: a consequence of cognitive slowing?

Bénédicte Giffard1, Béatrice Desgranges, Nacer Kerrouche, Pascale Piolino, Francis Eustache.   

Abstract

Increased semantic priming effects (hyperpriming) are sometimes observed in Alzheimer's disease (AD) and in normal aging. Whereas the processes underlying this phenomenon are now well understood in AD, the interpretation is much more woolly in normal aging. To explore semantic priming, the authors used a lexical decision task in which the influence of attention and cognitive slowing was controlled. To explore the semantic organization, the words had coordinate (tiger-lion) or attribute relations (zebra-stripes). Priming scores of 21 older and 20 young participants were equivalent in the 2 conditions. These results reflect the integrity of semantic memory with normal aging and call into question some investigations showing hyperpriming for older participants; this may instead be an artifact of a general slowing effect.

Entities:  

Mesh:

Year:  2003        PMID: 14599272     DOI: 10.1037/0894-4105.17.4.594

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  4 in total

1.  Searching for the trace: the influence of age, lexical activation and working memory on sentence processing.

Authors:  Anthony J Angwin; Helen J Chenery; David A Copland; Elizabeth A Cardell; Bruce E Murdoch; John C L Ingram
Journal:  J Psycholinguist Res       Date:  2006-01

Review 2.  Aging and situation model processing.

Authors:  Gabrel A Radvansky; Katinka Dijkstra
Journal:  Psychon Bull Rev       Date:  2007-12

3.  The effect of feedback schedule manipulation on speech priming patterns and reaction time.

Authors:  Dana Slocomb; Kristie A Spencer
Journal:  J Psycholinguist Res       Date:  2008-09-12

Review 4.  How does decisional capacity evolve with normal cognitive aging: systematic review of the literature.

Authors:  Thomas Tannou; Séverine Koeberlé; Régis Aubry; Emmanuel Haffen
Journal:  Eur Geriatr Med       Date:  2019-10-12       Impact factor: 1.710

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.